Abstract | OBJECTIVES: BACKGROUND: METHODS: Twenty swine (24 +/- 0.4 kg) were randomized to one of four doses (0, 2, 5, and 7.5 mcg/kgmin) of dobutamine for the treatment of post- resuscitation myocardial dysfunction following 12.5 min of untreated ventricular fibrillation cardiac arrest. Cardiac function was measured at pre-arrest baseline and serially for 6 h post- resuscitation. Left ventricular function was evaluated by contrast ventriculograms, left ventricular pressures, +dP/dt, Tau, -dP/dt, and cardiac output. Myocardial oxygen consumption and myocardial blood flow were measured to assess the functional significance of any dobutamine-mediated heart rate responses. RESULTS:
Left ventricular dysfunction was evident at 25 min and peaked 4 h post- resuscitation. Significant (P < 0.05) improvements in ventricular systolic (EF, CO) and diastolic (LVEDP, Tau) function were evident within minutes of dobutamine initiation and persisted at 6h for the 5 and 7.5 mcg/kgmin groups. Tachycardia manifested with all dobutamine doses, but only affected myocardial oxygen consumption significantly (P < 0.05) at the highest dose (7.5 mcg/kgmin). CONCLUSIONS:
Dobutamine at 5 mcg/kgmin appears optimal for restoring systolic and diastolic function post- resuscitation without adversely affecting myocardial oxygen consumption.
|
Authors | Alejandro Vasquez, Karl B Kern, Ronald W Hilwig, Joseph Heidenreich, Robert A Berg, Gordon A Ewy |
Journal | Resuscitation
(Resuscitation)
Vol. 61
Issue 2
Pg. 199-207
(May 2004)
ISSN: 0300-9572 [Print] Ireland |
PMID | 15135197
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Analysis of Variance
- Animals
- Cardiopulmonary Resuscitation
(adverse effects, methods)
- Disease Models, Animal
- Dobutamine
(pharmacology)
- Dose-Response Relationship, Drug
- Female
- Hemodynamics
(drug effects, physiology)
- Male
- Probability
- Random Allocation
- Risk Factors
- Sensitivity and Specificity
- Survival Rate
- Sus scrofa
- Ventricular Dysfunction, Left
(drug therapy, etiology)
- Ventricular Fibrillation
(therapy)
|